StockData
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

Surgery Partners, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$14.71+0.10 (+0.68%)

Close on Oct 19, 2026

Market cap
$1.90B
P/E (TTM)
–
Dividend yield
–

Surgery Partners statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-General Medical & Surgical Hospitals, NEC companies for comparison

Valuation

MeasureSurgery PartnersIndustry median
Market Cap$1.93B$1.14B
Enterprise Value$6.89B$1.35B
PS Ratio0.571.63
PB Ratio1.153.03
P/FCF Ratio10.2720.54
P/OCF Ratio7.4615.44

Enterprise value

MeasureSurgery PartnersIndustry median
EV / Sales2.051.78
EV / EBITDA12.2814.40
EV / EBIT17.9619.04
EV / FCF36.7323.16

Income (trailing twelve months)

MeasureSurgery PartnersIndustry median
Revenue$3.37B$561.90M
Operating Income$383.80M-$1.81M
Net Income-$88.60M-$1.16M
EBITDA$561.00M-$20.72K
EPS (Diluted)-$0.70-$0.02

Margins

MeasureSurgery PartnersIndustry median
Operating Margin11.4%-4.45%
Profit Margin-2.63%-2.91%
EBITDA Margin16.7%2.41%
FCF Margin5.57%3.13%

Returns

MeasureSurgery PartnersIndustry median
Return on Equity (ROE)-5.18%1.84%
Return on Assets (ROA)-1.11%-3.06%
Return on Invested Capital (ROIC)5.90%2.11%
Return on Capital Employed (ROCE)5.14%-0.57%

Growth

MeasureSurgery PartnersIndustry median
Revenue Growth (YoY)3.99%6.92%
FCF Growth (YoY)7.02%-6.04%
Revenue Growth (3Y CAGR)9.22%10.9%
Revenue Growth (5Y CAGR)12.2%13.2%

Balance sheet

MeasureSurgery PartnersIndustry median
Cash & Short-Term Investments$216.70M$48.71M
Total Debt$3.75B$140.00M
Net Cash (Debt)-$3.53B$205.49K
Net Cash Per Share-$27.00$0.01
Equity (Book Value)$1.67B$235.16M
Book Value Per Share$12.76$3.48
Tangible Book Value-$3.53B$703.69K
Working Capital$547.50M$30.48M

Financial position

MeasureSurgery PartnersIndustry median
Current Ratio1.951.40
Quick Ratio1.441.02
Debt / Equity2.250.66
Debt / EBITDA6.692.61
Debt / FCF20.004.59
Net Debt / EBITDA6.302.15

Cash flow (trailing twelve months)

MeasureSurgery PartnersIndustry median
Operating Cash Flow$258.00M$3.10M
Capital Expenditures-$70.40M-$18.62M
Free Cash Flow$187.60M$23.73M
FCF Per Share$1.43$0.37

Efficiency

MeasureSurgery PartnersIndustry median
Asset Turnover0.420.87
Revenue Per Employee$210.39K$228.48K
Profits Per Employee-$5.54K-$8.65K
Employee Count16,000913

Dividends and yields

MeasureSurgery PartnersIndustry median
Earnings Yield-4.60%-1.25%
FCF Yield9.74%1.74%

Shares

MeasureSurgery PartnersIndustry median
Shares Outstanding130,918,00058,282,400
Shares Change (YoY)1.28%2.68%
Shares Change (QoQ)0.07%0.32%
Float18,427,00033,780,100
Shares Held by Insiders85.9%16.4%
Shares Held by Institutions120.5%85.9%

Taxes

MeasureSurgery PartnersIndustry median
Income Tax$20.50M$697.00K

Scores

MeasureSurgery PartnersIndustry median
Altman Z-Score0.741.96
Piotroski F-Score45

Calculated by StockData from Surgery Partners's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.